Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Onesource Specialty Pharma Limited

ONESOURCE · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹1,563.00

−₹6.60 (−0.42%)(1D)

₹1,057.0052 Week Range₹1,925.00

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

34/100

Valuation

49/100

Quality

1/100

Growth

32/100

Health

64/100

Momentum

40/100

Valuation
49
Quality
1
Growth
32
Health
64
Momentum
40

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Onesource Specialty Pharma Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹1,563

Market cap

₹17,917 Cr

P/E ratio

Not available

P/B ratio

3.07

Dividend yield

Not available

ROE

Not available

RSI 14

58.19

1Y return

Onesource Specialty Pharma Limited FAQs

3 topics

ExpandCollapse

Not available

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Onesource Specialty Pharma Limited (ONESOURCE) stock page cover?

Onesource Specialty Pharma Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for ONESOURCE?

Onesource Specialty Pharma Limited is currently shown with a delayed price near ₹1,563, P/E N/A.

Does the ONESOURCE page provide investment advice?

No. The ONESOURCE page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

CONCORDBIO

Concord Biotech Limited · Healthcare

BLUEJET

Blue Jet Healthcare Limited · Healthcare

ANTHEM

Anthem Biosciences Limited · Healthcare

Shareholding Pattern Analysis

Learn how promoter, FII, DII, mutual fund, and public ownership changes can inform Indian stock research on Anvest.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Onesource Specialty Pharma Limited operates in the pharmaceutical sector, focusing on Contract Development and Manufacturing Organization (CDMO) services and a multimodal facility. The company generates revenue from these segments.

BiotechnologyFounded:2007CEO/MD:Neeraj Sharma

Business profile as of 2026-08-25

Revenue growth: -1.6%FY26 growth

What Looks Strong

Balance SheetConservative capital structure with manageable leverage of 0.22× Debt/Equity.
ValuationPrice/book is 3.1×. The valuation score is 95/100.

What to Watch

MarginsOperating margin is thin at 1.8%, leaving limited buffer against input cost volatility. Watch gross margin and cost lines in the next results.

Reports a single operating segment in its results filings.
It also operates a multimodal facility, contributing to its overall earnings.

FY26 (consolidated): revenue ₹1,422 cr, down 2% from ₹1,445 cr in FY25; the net loss widened to ₹73.8 cr from ₹18.0 cr in FY25.
FY26 (consolidated): operating cash flow ₹8.5 cr; debt/equity 0.22×.